COVID-19 : drug therapeutic options.

Overview

The emerging novel coronavirus outbreak (COVID-19) represents a global challenge and a crucial query concerns its prevention and treatment.

Summary

Cardiologists should be aware of the risk of COVID-19 drug effects, interactions and toxicities as well of the current precautions and opportunities. Worldwide there is a great expectancy of a vaccine. Several clinical trials have already been conducted or are currently ongoing evaluating drugs and it will be important to helping treat COVID-19 patients

Author Comments

Dr. Salvatore Patanè, MD
Dr. Salvatore Patanè, MD
Cardiologia Ospedale San Vincenzo Taormina (Me) Azienda Sanitaria Provinciale di Messina, Contrada Sirina, 98039 Taormina (Messina), Italia ✉ mail patane-@libero.it Department ♥ ♥ ♥ Cardiology ♥ ♥ ♥
Cardiologo. Cardiology First Level Medical Dirigent Taormina Hospital ASP Messina, Italy
Cardiology
Taormina (Me) , Sicilia | Italy
The world is desperately waiting for an effective and safe therapy for Covid-19 in the hope that an equally effective and safe vaccine will soon arriveDr. Salvatore Patanè, MD

Resources

COVID-19 and the Cardiologist : Drug Therapeutic Options.

Journal of Cardiology and Therapy

Journal of Cardiology and Therapy 2020; July; 7(1): 931-938 DOI: 10.17554/j.issn.2309-6861. 2020.07.180 http://www.ghrnet.org/index.php/jct/article/view/2930/3245

COVID-19 and the Cardiologist: Drug Therapeutic Options.

June 2020
51 Reads

Similar Publications